These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19515371)

  • 1. Lipoprotein particle subclasses, cardiovascular disease and HIV infection.
    Duprez DA; Kuller LH; Tracy R; Otvos J; Cooper DA; Hoy J; Neuhaus J; Paton NI; Friis-Moller N; Lampe F; Liappis AP; Neaton JD;
    Atherosclerosis; 2009 Dec; 207(2):524-9. PubMed ID: 19515371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.
    Lampe FC; Duprez DA; Kuller LH; Tracy R; Otvos J; Stroes E; Cooper DA; Hoy J; Paton NI; Friis-Møller N; Neuhaus J; Liappis AP; Phillips AN;
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):275-84. PubMed ID: 20658749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.
    De Luca A; de Gaetano Donati K; Colafigli M; Cozzi-Lepri A; De Curtis A; Gori A; Sighinolfi L; Giacometti A; Capobianchi MR; D'Avino A; Iacoviello L; Cauda R; D'Arminio Monforte A
    BMC Infect Dis; 2013 Sep; 13():414. PubMed ID: 24004495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
    Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
    PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.
    Baker JV; Neuhaus J; Duprez D; Cooper DA; Hoy J; Kuller L; Lampe FC; Liappis A; Friis-Moller N; Otvos J; Paton NI; Tracy R; Neaton JD;
    AIDS; 2011 Nov; 25(17):2133-42. PubMed ID: 21857489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
    Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
    Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
    J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
    Phillips AN; Carr A; Neuhaus J; Visnegarwala F; Prineas R; Burman WJ; Williams I; Drummond F; Duprez D; Belloso WH; Goebel FD; Grund B; Hatzakis A; Vera J; Lundgren JD
    Antivir Ther; 2008; 13(2):177-87. PubMed ID: 18505169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.
    Duprez DA; Neuhaus J; Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon D; Paton NI; Prineas RJ; Neaton JD;
    PLoS One; 2012; 7(9):e44454. PubMed ID: 22970224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.
    McGarrah RW; Craig DM; Haynes C; Dowdy ZE; Shah SH; Kraus WE
    Atherosclerosis; 2016 Mar; 246():229-35. PubMed ID: 26803432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
    Nordell AD; McKenna M; Borges ÁH; Duprez D; Neuhaus J; Neaton JD; ;
    J Am Heart Assoc; 2014 May; 3(3):e000844. PubMed ID: 24870935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.
    Munger AM; Chow DC; Playford MP; Parikh NI; Gangcuangco LM; Nakamoto BK; Kallianpur KJ; Ndhlovu LC; Shikuma CM; Mehta NN
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):221-8. PubMed ID: 25416403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.
    Tien PC; Schneider MF; Cox C; Cohen M; Karim R; Lazar J; Young M; Glesby MJ
    AIDS; 2010 Nov; 24(18):2809-17. PubMed ID: 20871387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.